Advertisement

Ischemic stroke outcome: A review of the influence of post-stroke complications within the different scenarios of stroke care

Published:December 23, 2015DOI:https://doi.org/10.1016/j.ejim.2015.11.030

      Highlights

      • Stroke is the fourth cause of death and the second cause of disability.
      • Stroke outcome depends on baseline characteristics and post-stroke complications.
      • Different post-stroke complications should be managed depending on time from stroke.
      • Prediction and early management of post-stroke complications might improve outcome.

      Abstract

      Stroke remains one of the main causes of death and disability worldwide. The challenge of predicting stroke outcome has been traditionally assessed from a general point of view, where baseline non-modifiable factors such as age or stroke severity are considered the most relevant factors. However, after stroke occurrence, some specific complications such as hemorrhagic transformations or post stroke infections, which lead to a poor outcome, could be developed. An early prediction or identification of these circumstances, based on predictive models including clinical information, could be useful for physicians to individualize and improve stroke care. Furthermore, the addition of biological information such as blood biomarkers or genetic polymorphisms over these predictive models could improve their prognostic value. In this review, we focus on describing the different post-stroke complications that have an impact in short and long-term outcome across different time points in its natural history and on the clinical-biological information that might be useful in their prediction.

      Graphical abstract

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to European Journal of Internal Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Krishnamurthi R.V.
        • Feigin V.L.
        • Forouzanfar M.H.
        • Mensah G.A.
        • Connor M.
        • Bennett D.A.
        • et al.
        on behalf of the global burden of diseases, injuries, risk factors study 2010 (GBD 2010) and the GBD stroke experts group. Global and regional burden of first-ever ischaemic and haemorrhagic stroke during 1990–2010: findings from the global burden of disease study 2010.
        Lancet Glob Health. 2013; 1: e259-e281
        • Feigin V.L.
        • Lawes C.M.M.
        • Bennett D.A.
        • Barker-Collo S.L.
        • Parag V.
        Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review.
        Lancet Neurol. 2009; 8: 355-369
        • Go A.S.
        • Mozaffarian D.
        • Roger V.L.
        • Benjamin E.J.
        • Berry J.D.
        • Blaha M.J.
        • et al.
        American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics–2014 update: a report from the American Heart Association.
        Circulation. 2014; 129: e28-e292
        • Johnston S.C.
        • Mendis S.
        • Mathers C.D.
        Global variation in stroke burden and mortality: estimates from monitoring, surveillance, and modelling.
        Lancet Neurol. 2009; 8: 345-354
        • Brott T.
        • Adams Jr., H.P.
        • Olinger C.P.
        • Marler J.R.
        • Barsan W.G.
        • Biller J.
        • et al.
        Measurements of acute cerebral infarction: a clinical examination scale.
        Stroke. 1989; 20: 864-870
        • Brott T.G.
        • Haley Jr., E.C.
        • Levy D.E.
        • Barsan W.
        • Broderick J.
        • Sheppard G.L.
        • et al.
        Urgent therapy for stroke. Part I. Pilot study of tissue plasminogen activator administered within 90 minutes.
        Stroke. 1992; 23: 632-640
        • Seners P.
        • Turc G.
        • Oppenheim C.
        • Baron J.C.
        Incidence, causes and predictors of neurological deterioration occurring within 24 h following acute ischaemic stroke: a systematic review with pathophysiological implications.
        J Neurol Neurosurg Psychiatry. 2015; 86: 87-94
        • Tsivgoulis G.
        • Apostolidou N.
        • Giannopoulos S.
        • Sharma V.K.
        Hemodynamic causes of deterioration in acute ischemic stroke.
        Pers Med. 2012; 1: 177-184
        • Thanvi B.
        • Treadwell S.
        • Robinson T.
        Early neurological deterioration in acute ischaemic stroke: predictors, mechanism and management.
        Postgrad Med J. 2008; 84: 412-417
        • Siegler J.E.
        • Martin-Schild S.
        Early neurological deterioration (END) after stroke: the END depends on the definition.
        Int J Stroke. 2011; 6: 211-212
        • Higashida R.T.
        • Furlan A.J.
        • Roberts H.
        • Tomsick T.
        • Connors B.
        • Barr J.
        • et al.
        Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
        Stroke. 2003; 3: e109-e137
        • World Health Organization
        The WHO stroke surveillance.
        World Health Organization, 2004
        • Van Swieten J.C.
        • Koudstaal P.J.
        • Visser M.C.
        • Schouten H.J.
        • van Gijn J.
        Interobserver agreement for the assessment of handicap in stroke patients.
        Stroke. 1988; 19: 604-607
        • Saver J.L.
        Optimal end points for acute stroke therapy trials: best ways to measure treatment effects of drugs and devices.
        Stroke. 2011; 42: 2356-2362
        • Appelros P.
        • Nydevik I.
        • Viitanen M.
        Poor outcome after first-ever stroke: predictors for death, dependency, and recurrent stroke within the first year.
        Stroke. 2003; 34: 122-126
        • Saposnik G.
        • Hill M.D.
        • O’Donnell M.
        • Fang J.
        • Hachinski V.
        • Kapral M.K.
        Variables associated with 7-day, 30-day, and 1-year fatality after ischemic stroke.
        Stroke. 2008; 39: 2318-2324
        • Bushnell C.
        Another score to predict ischemic stroke mortality?.
        Circulation. 2011; 123: 712-713
        • Saposnik G.
        • Cote R.
        • Mamdani M.
        • Raptis S.
        • Thorpe K.E.
        • Fang J.
        • et al.
        JURaSSIC: accuracy of clinician vs. risk score prediction of ischemic stroke outcomes.
        Neurology. 2013; 81: 448-455
        • Moons K.G.M.
        • Royston P.
        • Vergouwe Y.
        • Grobbee D.E.
        • Altman D.G.
        Prognosis and prognostic research: what, why and how?.
        BMJ. 2009; 338: b375
        • Counsell C.
        • Dennis M.
        Systematic review of prognostic models in patients with acute stroke.
        Cerebrovasc Dis. 2001; 12: 159-170
        • Saposnik G.
        • Raptis S.
        • Kapral M.K.
        • Liu Y.
        • Tu J.V.
        • Mamdani M.
        • et al.
        on behalf of the investigators of the registry of the Canadian Stroke Network and the Stroke Outcomes Research Canada working group. The iScore predicts poor functional outcomes early after hospitalization for an acute ischemic stroke.
        Stroke. 2011; 42: 3421-3428
        • Ntaios G.
        • Faouzi M.
        • Ferrari J.
        • Lang W.
        • Vemmos K.
        • Michel P.
        An integer-based score to predict functional outcome in acute ischemic stroke: the ASTRAL score.
        Neurology. 2012; 78: 1916-1922
        • O’Donnell M.J.
        • Fang J.
        • D’Uva C.
        • Saposnik G.
        • Gould L.
        • McGrath E.
        • et al.
        For the investigators of the registry of the Canadian Stroke Network. The PLAN score. A bedside prediction rule for death and severe disability following acute ischemic stroke.
        Arch Intern Med. 2012; 172: 1548-1556
        • Strbian D.
        • Seiffge D.J.
        • Breuer L.
        • Numminen H.
        • Michel P.
        • Meretoja A.
        • et al.
        Validation of the DRAGON score in 12 stroke centers in anterior and posterior circulation.
        Stroke. 2013; 44: 2718-2721
        • Koennecke H.C.
        • Belz W.
        • Berfelde D.
        • Endres M.
        • Fitzek S.
        • Hamilton F.
        • et al.
        Factors influencing in-hospital mortality and morbidity in patients treated on a stroke unit.
        Neurology. 2011; 77: 965-972
        • Grube M.M.
        • Koennecke H.C.
        • Walter G.
        • Meisel A.
        • Sobesky J.
        • Nolte C.H.
        • et al.
        Influence of acute complications on outcome 3 months after ischemic stroke.
        PLoS One. 2013; 24: 8e75719
        • The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group
        Tissue plasminogen activator for acute ischemic stroke.
        N Engl J Med. 1995; 333: 1581-1587
        • Berkhemer O.A.
        • Fransen P.S.
        • Beumer D.
        • van den Berg L.A.
        • Lingsma H.F.
        • Yoo A.J.
        • et al.
        MR CLEAN Investigators. A randomized trial of intraarterial treatment for acute ischemic stroke.
        N Engl J Med. 2015; 372: 11-20
        • Goyal M.
        • Demchuk A.M.
        • Menon B.K.
        • Eesa M.
        • Rempel J.L.
        • Thornton J.
        • et al.
        ESCAPE Trial Investigators. Randomized assessment of rapid endovascular treatment of ischemic stroke.
        N Engl J Med. 2015; 372: 1019-1030
        • Campbell B.C.
        • Mitchell P.J.
        • Kleinig T.J.
        • Dewey H.M.
        • Churilov L.
        • Yassi N.
        • et al.
        EXTEND-IA Investigators. Endovascular therapy for ischemic stroke with perfusion-imaging selection.
        N Engl J Med. 2015; 372: 1009-1018
        • Jovin T.G.
        • Chamorro A.
        • Cobo E.
        • de Miquel M.A.
        • Molina C.A.
        • Rovira A.
        REVASCAT trial investigators. thrombectomy within 8 hours after symptom onset in ischemic stroke.
        N Engl J Med. 2015; ([Epub ahead of print])
        • Saqqur M.
        • Uchino K.
        • Demchuk A.M.
        • Molina C.A.
        • Garami Z.
        • Calleja S.
        • Investigators C.L.O.T.B.U.S.T.
        • et al.
        Site of arterial occlusion identified by transcranial Doppler (TCD) predicts the response to intravenous thrombolysis for stroke.
        Stroke. 2007; 38: 948-954
        • Burgin W.S.
        • Alexandrov A.V.
        Deterioration following improvement with tPA therapy: carotid thrombosis and reocclusion.
        Neurology. 2001; 56: 568-570
        • Alexandrov A.V.
        • Grotta J.C.
        Arterial reocclusion in stroke patients treated with intravenous tissue plasminogen activator.
        Neurology. 2002; 59: 862-867
        • Rubiera M.
        • Alvarez-Sabín J.
        • Ribo M.
        • Montaner J.
        • Santamarina E.
        • Arenillas J.F.
        • et al.
        Predictors of early arterial reocclusion after tissue plasminogen activator-induced recanalization in acute ischemic stroke.
        Stroke. 2005; 36: 1452-1456
        • Ribo M.
        • Montaner J.
        • Molina C.A.
        • Arenillas J.F.
        • Santamarina E.
        • Alvarez-Sabín J.
        Admission fibrinolytic profile predicts clot lysis resistance in stroke patients treated with tissue plasminogen activator.
        Thromb Haemost. 2004; 91: 1146-1151
        • Fernandez-Cadenas I.
        • Del Rio-Espinola A.
        • Rubiera M.
        • Mendioroz M.
        • Domingues-Montanari S.
        • Cuadrado E.
        • et al.
        PAI-1 4G/5G polymorphism is associated with brain vessel reocclusion after successful fibrinolytic therapy in ischemic stroke patients.
        Int J Neurosci. 2010; 120: 245-251
        • del Río-Espínola A.
        • Fernández-Cadenas I.
        • Rubiera M.
        • Quintana M.
        • Domingues-Montanari S.
        • Mendióroz M.
        • et al.
        CD40-1C > T polymorphism (rs1883832) is associated with brain vessel reocclusion after fibrinolysis in ischemic stroke.
        Pharmacogenomics. 2010; 11: 763-772
        • Lindley R.
        • Wardlaw J.M.
        • Sandercock P.A.G.
        • Rimdusid P.
        • Lewis S.C.
        • Signorini D.F.
        • et al.
        Frequency and risk factors for spontaneous hemorrhagic transformation of cerebral infarction.
        J Stroke Cerebrovasc Dis. 2004; 13: 235-246
        • Balami J.S.
        • Chen R.L.
        • Grunwald I.Q.
        • Buchan A.M.
        Neurological complications of acute ischaemic stroke.
        Lancet Neurol. 2011; 10: 357-371
        • Hacke W.
        • Kaste M.
        • Fieschi C.
        • Toni D.
        • Lesaffre E.
        • von Kummer R.
        • for the ECASS Study Group
        • et al.
        Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: the European Cooperative Acute Stroke Study (ECASS).
        JAMA. 1995; 274: 1017-1025
        • Molina C.A.
        • Alvarez-Sabín J.
        • Montaner J.
        • Abilleira S.
        • Arenillas J.F.
        • Coscojuela P.
        • et al.
        Thrombolysis-related hemorrhagic infarction: a marker of early reperfusion, reduced infarct size, and improved outcome in patients with proximal middle cerebral artery occlusion.
        Stroke. 2002; 33: 1551-1556
        • Molina C.A.
        • Montaner J.
        • Abilleira S.
        • Ibarra B.
        • Romero F.
        • Arenillas J.F.
        • et al.
        Timing of spontaneous recanalization and risk of hemorrhagic transformation in acute cardioembolic stroke.
        Stroke. 2001; 32: 1079-1084
        • Lansberg M.G.
        • Albers G.W.
        • Wijman C.A.
        Symptomatic intracerebral hemorrhage following thrombolytic therapy for acute ischemic stroke: a review of the risk factors.
        Cerebrovasc Dis. 2007; 24: 1-10
        • Khatri P.
        • Wechsler L.R.
        • Broderick J.P.
        Intracranial hemorrhage associated with revascularization therapies.
        Stroke. 2007; 38: 431-440
        • Lou M.
        • Safdar A.
        • Mehdiratta M.
        • Kumar S.
        • Schlaug G.
        • Caplan L.
        • et al.
        The HAT score: a simple grading scale for predicting hemorrhage after thrombolysis.
        Neurology. 2008; 71: 1417-1423
        • Menon B.K.
        • Saver J.L.
        • Prabhakaran S.
        • Reeves M.
        • Liang L.
        • Olson D.W.M.
        • et al.
        Risk score for intracranial hemorrhage in patients with acute ischemic stroke treated with intravenous tissue-type plasminogen activator.
        Stroke. 2012; 43: 2293-2299
        • Strbian D.
        • Engelter S.
        • Michel P.
        • Meretoja A.
        • Sekoranja L.
        • Ahlhelm F.J.
        • et al.
        Symptomatic intracranial hemorrhage after stroke thrombolysis: the SEDAN score.
        Ann Neurol. 2012; 71: 634-641
        • Strbian D.
        • Michel P.
        • Seiffge D.J.
        • Saver J.L.
        • Numminen H.
        • Meretoja A.
        • et al.
        Symptomatic intracranial hemorrhage after stroke thrombolysis: comparison of prediction scores.
        Stroke. 2014; 45: 752-758
        • Montaner J.
        • Molina C.A.
        • Monasterio J.
        • Abilleira S.
        • Arenillas J.F.
        • Ribo M.
        • et al.
        J. Matrix metalloproteinase-9 pretreatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke.
        Circulation. 2003; 107: 598-603
        • Foerch C.
        • Wunderlich M.T.
        • Dvorak F.
        • Humpich M.
        • Kahles T.
        • Goertler M.
        • et al.
        Elevated serum S100B levels indicate a higher risk of hemorrhagic transformation after thrombolytic therapy in acute stroke.
        Stroke. 2007; 38: 2491-2495
        • Castellanos M.
        • Sobrino T.
        • Millan M.
        • Garcia M.
        • Arenillas J.
        • Nombela F.
        • et al.
        Serum cellular fibronectin and matrix metalloproteinase-9 as screening biomarkers for the prediction of parenchymal hematoma after thrombolytic therapy in acute ischemic stroke: a multicenter confirmatory study.
        Stroke. 2007; 38: 1855-1859
        • del Río-Espínola A.
        • Fernández-Cadenas I.
        • Giralt D.
        • Quiroga A.
        • Gutiérrez-Agulló M.
        • Quintana M.
        • et al.
        A predictive clinical-genetic model of tissue plasminogen activator response in acute ischemic stroke.
        Ann Neurol. 2012; 72: 716-729
        • Nogueira R.G.
        • Gupta R.
        • Jovin T.G.
        • Levy E.I.
        • Liebeskind D.S.
        • Zaidat O.O.
        • et al.
        Predictors and clinical relevance of hemorrhagic transformation after endovascular therapy for anterior circulation large vessel occlusion strokes: a multicenter retrospective analysis of 1122 patients.
        J Neurointerv Surg. 2015; 7: 16-21
        • Boehme A.K.
        • Rawal P.V.
        • Lyerly M.J.
        • Albright K.C.
        • Bavarsad Shahripour R.
        • et al.
        Investigating the utility of previously developed prediction scores in acute ischemic stroke patients in the stroke belt.
        J Stroke Cerebrovasc Dis. 2014; 23: 2001-2006
        • Hacke W.
        • Schwab S.
        • Horn M.
        • Spranger M.
        • De Georgia M.
        • von Kummer R.
        ‘Malignant’ middle cerebral artery territory infarction: clinical course and prognostic signs.
        Arch Neurol. 1996; 53: 309-315
        • Vahedi K.
        • Hofmeijer J.
        • Juettler E.
        • Vicaut E.
        • George B.
        • Algra A.
        • et al.
        DECIMAL, DESTINY, and HAMLET investigators. Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials.
        Lancet Neurol. 2007; 6: 215-222
        • Wartenberg K.E.
        Malignant middle cerebral artery infarction.
        Curr Opin Crit Care. 2012; 18: 152-163
        • Foerch C.
        • Otto B.
        • Singer O.C.
        • Neumann-Haefelin T.
        • Yan B.
        • Berkefeld J.
        • et al.
        Serum S100B predicts a malignant course of infarction in patients with acute middle cerebral artery occlusion.
        Stroke. 2004; 35: 2160-2164
        • Serena J.
        • Blanco M.
        • Castellanos M.
        • Silva Y.
        • Vivancos J.
        • Moro M.A.
        • et al.
        The prediction of malignant cerebral infarction by molecular brain barrier disruption markers.
        Stroke. 2005; 36: 1921-1926
        • Hauser W.A.
        Seizure disorders.
        Epilepsia. 1992; 33: S6-S14
        • Commission on classification and terminology of the International League Against Epilepsy (ILAE)
        Proposal for revised clinical end electroencephalographic classification of epileptic seizures.
        Epilepsia. 1981; 22: 489-501
        • Beghi E.
        • D'Alessandro R.
        • Beretta S.
        • Consoli D.
        • Crespi V.
        • Delaj L.
        • et al.
        Incidence and predictors of acute symptomatic seizures after stroke.
        Neurology. 2011; 77: 1785-1793
        • Bladin C.
        • Alexandrov A.
        • Bellavance A.
        • Bornstein N.
        • Chambers B.
        • Coté R.
        • et al.
        Seizures after stroke: a prospective multicenter study.
        Arch Neurol. 2000; 57: 1617-1628
        • Burneo J.G.
        • Fang J.
        • Saposnik G.
        investigators of the registry of the Canadian Stroke Network impact of seizures on morbidity and mortality after stroke: a Canadian multi-centre cohort study.
        Eur J Neurol. 2010; 17: 52-58
        • Alvarez-Sabín J.
        • Montaner J.
        • Padró L.
        • Molina C.A.
        • Rovira R.
        • Codina A.
        • et al.
        Gabapentin in late-onset poststroke seizures.
        Neurology. 2002; 59: 1991-1993
        • Kumar S.
        • Selim M.H.
        • Caplan L.R.
        Medical complications after stroke.
        Lancet Neurol. 2010; 9: 105-118
        • Adams R.J.
        • Chimowitz M.I.
        • Alpert J.S.
        • Awad I.A.
        • Cerqueria M.D.
        • Fayad P.
        • et al.
        Coronary risk evaluation in patients with transient ischemic attack and ischemic stroke: a scientific statement for healthcare professionals from the stroke council and the council on clinical cardiology of the American Heart Association/Am Stroke Association.
        Stroke. 2003; 34: 2310-2322
        • Prosser J.
        • MacGregor L.
        • Lees K.R.
        • Diener H.C.
        • Hacke W.
        • Davis S.
        • et al.
        Predictors of early cardiac morbidity and mortality after ischemic stroke.
        Stroke. 2007; 38: 2295-2302
        • Arenillas J.F.
        • Candell-Riera J.
        • Romero-Farina G.
        • Molina C.A.
        • Chacón P.
        • Aguadé-Bruix S.
        • et al.
        Silent myocardial ischemia in patients with symptomatic intracranial atherosclerosis: associated factors.
        Stroke. 2005; 36: 1201-1206
        • Touze E.
        • Varenne O.
        • Chatellier G.
        • Peyrard S.
        • Rothwell P.M.
        • Mas J.L.
        Risk of myocardial infarction and vascular death after transient ischemic attack and ischemic stroke: a systematic review and meta-analysis.
        Stroke. 2005; 36: 2748-2755
        • Liao J.
        • O'Donnell M.J.
        • Silver F.L.
        • Thiruchelvam D.
        • Saposnik G.
        • Fang J.
        • et al.
        In-hospital myocardial infarction following acute ischaemic stroke: an observational study.
        Eur J Neurol. 2009; 16: 1035-1040
        • Rem J.A.
        • Hachinski V.C.
        • Boughner D.R.
        Value of cardiac monitoring and echocardiography after TIA and stroke patients.
        Stroke. 1985; 16: 950-956
        • Daniele O.
        • Caravaglios G.
        • Fierro B.
        • Natale E.
        Stroke and cardiac arrhythmias.
        J Stroke Cerebrovasc Dis. 2002; 11: 28-33
        • Bybee K.A.
        • Kara T.
        • Prasad A.
        Systematic review: transient left ventricular apical ballooning: a syndrome that mimics ST segment elevation myocardial infarction.
        Ann Intern Med. 2004; 141: 858-865
        • Westendorp W.F.
        • Nederkoorn P.J.
        • Vermeij J.D.
        • Dijkgraaf M.G.
        • van de Beek D.
        Post-stroke infection: a systematic review and meta-analysis.
        BMC Neurol. 2011; 11: 110
        • Heuschmann P.U.
        • Kolominsky-Rabas P.L.
        • Misselwitz B.
        • Hermanek P.
        • Leffmann C.
        • Janzen R.W.
        • et al.
        Predictors of in-hospital mortality and attributable risks of death after ischemic stroke: the German Stroke Registers Study Group.
        Arch Intern Med. 2004; 164: 1761-1768
        • Katzan I.L.
        • Dawson N.V.
        • Thomas C.L.
        • Votruba M.E.
        • Cebul R.D.
        The cost of pneumonia after acute stroke.
        Neurology. 2007; 68: 1938-1943
        • Katzan I.L.
        • Cebul R.D.
        • Husak S.H.
        • Dawson N.V.
        • Baker D.W.
        The effect of pneumonia on mortality among patients hospitalized for acute stroke.
        Neurology. 2003; 60: 620-625
        • Meisel C.
        • Prass K.
        • Braun J.
        • Victorov I.
        • Wolf T.
        • Megow D.
        • et al.
        Preventive antibacterial treatment improves the general medical and neurological outcome in a mouse model of stroke.
        Stroke. 2004; 35: 2-6
        • Chamorro A.
        • Horcajada J.P.
        • Obach V.
        • Vargas M.
        • Revilla M.
        • Torres F.
        The early systemic prophylaxis of infection after stroke study: a randomized clinical trial.
        Stroke. 2005; 36: 1495-1500
        • Schwarz S.
        • Al-Shajlawi F.
        • Sick C.
        • Meairs S.
        • Hennerici M.G.
        Effects of prophylactic antibiotic therapy with mezlocillin plus Sulbactam on the incidence and height of fever after severe acute ischemic stroke: the Mannheim infection in stroke study (MISS).
        Stroke. 2008; 39: 1220-1227
        • Harms H.
        • Prass K.
        • Meisel C.
        • Klehmet J.
        • Rogge W.
        • Drenckhahn C.
        Preventive antibacterial therapy in acute ischemic stroke: a randomized controlled trial.
        PLoS One. 2008; 3e2158
        • Westendorp W.F.
        • Vermeij J.D.
        • Vermeij F.
        • Den Hertog H.M.
        • Dippel D.W.
        • van de Beek D.
        • et al.
        Antibiotic therapy for preventing infections in patients with acute stroke.
        Cochrane Database Syst Rev. 2012; 18 ([CD008530])
        • Westendorp W.F.
        • Vermeij J.D.
        • Zock E.
        • Hooijenga I.J.
        • Kruyt N.D.
        • Bosboom H.J.
        • et al.
        for the PASS investigators. The Preventive Antibiotics in Stroke Study (PASS): a pragmatic randomised open-label masked endpoint clinical trial.
        Lancet. 2015; ([Epub ahead of print])
        • Sellars C.
        • Bowie L.
        • Bagg J.
        • Sweeney M.P.
        • Miller H.
        • Tilston J.
        Risk factors for chest infection in acute stroke: a prospective cohort study.
        Stroke. 2007; 38: 2284-2291
        • Perry L.
        • Love C.P.
        Screening for dysphagia and aspiration in acute stroke: a systematic review.
        Dysphagia. 2001; 16: 7-18
        • Hoffmann S.
        • Malzahn U.
        • Harms H.
        • Koennecke H.C.
        • Berger K.
        • Kalic M.
        • et al.
        Development of a clinical score (A2DS2) to predict pneumonia in acute ischemic stroke.
        Stroke. 2012; 43: 2617-2623
        • Harms H.
        • Grittner U.
        • Dröge H.
        • Meisel A.
        Predicting post-stroke pneumonia: the PANTHERIS score.
        Acta Neurol Scand. 2013; 128: 178-184
        • Ji R.
        • Shen H.
        • Pan Y.
        • Wang P.
        • Liu G.
        • Wang Y.
        • et al.
        China National Stroke Registry Investigators. Novel risk score to predict pneumonia after acute ischemic stroke.
        Stroke. 2013; 44: 1303-1309
        • Wartenberg K.E.
        • Stoll A.
        • Funk A.
        • Meyer A.
        • Schmidt J.M.
        • Berrouschot J.
        Infection after acute ischemic stroke: risk factors, biomarkers, and outcome.
        Stroke Res Treat. 2011; 2011: 830614
        • Fluri F.
        • Morgenthaler N.G.
        • Mueller B.
        • Christ-Crain M.
        • Katan M.
        Copeptin, procalcitonin and routine inflammatory markers – predictors of infection after stroke.
        PLoS One. 2012; 7e48309
        • Salat D.
        • Penalba A.
        • Garcia-Berrocoso T.
        • Campos-Martorell M.
        • Flores A.
        • Pagola J.
        • et al.
        Immunological biomarkers improve the accuracy of clinical risk models of infection in the acute phase of ischemic stroke.
        Cerebrovasc Dis. 2013; 35: 220-227
        • Ulm L.
        • Ohlraun S.
        • Harms H.
        • Hoffmann S.
        • Klehmet J.
        • Ebmeyer S.
        • et al.
        STRoke Adverse outcome is associated WIth NoSocomial Infections (STRAWINSKI): procalcitonin ultrasensitive-guided antibacterial therapy in severe ischemic stroke patients — rationale and protocol for a randomized controlled trial.
        Int J Stroke. 2013; 8: 598-603
        • Brandstater M.E.
        • Roth E.J.
        • Siebens H.C.
        Venous thromboembolism in stroke: literature review and implications for clinical practice.
        Arch Phys Med Rehabil. 1992; 73: S379-S391
        • Kelly J.
        • Hunt B.J.
        • Lewis R.R.
        • Swaminathan R.
        • Moody A.
        • Seed P.T.
        • et al.
        Dehydration and venous thromboembolism after acute stroke.
        Q JM. 2004; 97: 293-296
        • Kelly J.
        • Rudd A.
        • Lewis R.R.
        • Coshall C.
        • Moody A.
        • Hunt B.J.
        Venous thromboembolism after acute ischemic stroke: a prospective study using magnetic resonance direct thrombus imaging.
        Stroke. 2004; 35: 2320-2325
        • Dennis M.
        • Sandercock P.
        • Reid J.
        • Graham C.
        • Forbes J.
        • et al.
        • CLOTS (Clots in Legs Or sTockings after Stroke) Trials Collaboration
        Effectiveness of intermittent pneumatic compression in reduction of risk of deep vein thrombosis in patients who have had a stroke (CLOTS 3): a multicentre randomised controlled trial.
        Lancet. 2013; 382: 516-524
        • Davenport R.J.
        • Dennis M.S.
        • Warlow C.P.
        Gastrointestinal hemorrhage after acute stroke.
        Stroke. 1996; 27: 421-424
        • Lipowski Z.
        Delirium in geriatric patients. Delirium: acute confusional states.
        Oxford University Press, New York, NY1990
        • Oldenbeuving A.W.
        • de Kort P.L.
        • Jansen B.P.
        • Roks G.
        • Kappelle L.J.
        Delirium in acute stroke: a review.
        Int J Stroke. 2007; 2: 270-275
        • Fick D.M.
        • Agostini J.V.
        • Inouye S.K.
        Delirium superimposed on dementia: a systematic review.
        J Am Geriatr Soc. 2002; 50: 1723-1732
        • Shi Q.
        • Presutti R.
        • Selchen D.
        • Saposnik G.
        Delirium in acute stroke: a systematic review and meta-analysis.
        Stroke. 2012; 43: 645-649
        • Burn J.
        • Dennis M.
        • Bamford J.
        • Sandercock P.
        • Wade D.
        • Warlow C.
        Long-term risk of recurrent stroke after a first-ever stroke: the oxfordshire community stroke project.
        Stroke. 1994; 25: 333-337
        • Ay H.
        • Gunger L.
        • Arsava E.M.
        • Rosand J.
        • Vangel M.
        • Benner T.
        • et al.
        A score to predict early risk of recurrence after ischemic stroke.
        Neurology. 2010; 74: 128-135
        • Yusuf S.
        Two decades of progress in preventing vascular disease.
        Lancet. 2002; 360: 2-3
        • Touze E.
        • Coste J.
        • Voicu M.
        • Kansao J.
        • Masmoudi R.
        • Dooumenc B.
        • et al.
        Importance of in-hospital initiation of therapies and therapeutic inertia in secondary stroke prevention: IMplementation of prevention after a cerebrovascular evenT (IMPACT) study.
        Stroke. 2008; 39: 1834-1843
        • Joubert J.
        • Joubert L.B.
        • de Bustos E.M.
        • Ware D.
        • Jackson D.
        • Harrison T.
        • et al.
        Telestroke in stroke survivors.
        Cerebrovasc Dis. 2009; S4: 28-35
        • Joubert J.
        • Reid C.
        • Barton D.
        • Cumming T.
        • McLean A.
        • Joubert J.
        • et al.
        Integrated care improves risk-factor modification after stroke: initial results of the integrated care for the reduction of secondary stroke model.
        J Neurol Neurosurg Psychiatry. 2009; 80: 279-284
        • Scherbakov N.
        • von Haehling S.
        • Anker S.D.
        • Dirnagl U.
        • Doehner W.
        Stroke induced sarcopenia: muscle wasting and disability after stroke.
        Int J Cardiol. 2013; 170: 89-94
        • Gray V.
        • Rice C.L.
        • Garland S.J.
        Factors that influence muscle weakness following stroke and their clinical implications: a critical review.
        Physiother Can. 2012; 64: 415-426
        • Jonsson A.C.
        • Lindgren I.
        • Hallstrom B.
        • Norrving B.
        • Lindgren A.
        Prevalence and intensity of pain after stroke: a population based study focusing on patients' perspectives.
        J Neurol Neurosurg Psychiatry. 2006; 77: 590-595
        • Andersen G.
        • Vestergaard K.
        • Ingeman-Nielsen M.
        • Jensen T.S.
        Incidence of central post-stroke pain.
        Pain. 1995; 61: 187-193
        • Ingles J.L.
        • Eskes G.A.
        • Phillips S.J.
        Fatigue after stroke.
        Arch Phys Med Rehabil. 1999; 80: 173-178
        • Choi-Kwon S.
        • Han S.W.
        • Kwon S.U.
        • Kim J.S.
        Poststroke fatigue: characteristics and related factors.
        Cerebrovasc Dis. 2005; 19: 84-90
        • Ayerbe L.
        • Ayis S.
        • Wolfe C.D.
        • Rudd A.G.
        Natural history, predictors and outcomes of depression after stroke: systematic review and meta-analysis.
        BJP. 2013; 202: 14-21
        • Hackett M.L.
        • Yapa C.
        • Parag V.
        • Anderson C.S.
        Frequency of depression after stroke: a systematic review of observational studies.
        Stroke. 2005; 36: 1330-1340
        • Ayerbe L.
        • Ayis S.
        • Crichton S.
        • Wolfe C.D.
        • Rudd A.G.
        The long-term outcomes of depression up to 10 years after stroke; the South London rStroke Register.
        J Neurol Neurosurg Psychiatry. 2014; 85: 514-521
        • Jiménez I.
        • Sobrino T.
        • Rodríguez-Yáñez M.
        • Pouso M.
        • Cristobo I.
        • Sabucedo M.
        • et al.
        High serum levels of leptin are associated with post-stroke depression.
        Psychol Med. 2009; 39: 1201-1209
        • McKechnie F.
        • Lewis S.
        • Mead G.
        A pilot observational study of the association between fatigue after stroke and C-reactive protein.
        J R Coll Physicians Edinb. 2010; 40: 9-12
        • Zhan Y.
        • Yang Y.T.
        • You H.M.
        • Cao D.
        • Liu C.Y.
        • Zhou C.J.
        • et al.
        Plasma-based proteomics reveals lipid metabolic and immunoregulatory dysregulation in post-stroke depression.
        Eur Psychiatry. 2014; 29: 307-315
        • Gorelick P.B.
        • Scuteri A.
        • Black S.E.
        • Decarli C.
        • Greenberg S.M.
        • Iadecola C.
        • et al.
        American Heart Association Stroke Council, Council on Epidemiology and Prevention, Council on Cardiovascular Nursing, Council on Cardiovascular Radiology and Intervention, and Council on Cardiovascular Surgery and Anesthesia. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American heart association/American stroke association.
        Stroke. 2011; 42: 2672-2713
        • Ankolekar S.
        • Renton C.
        • Sare G.
        • Ellender S.
        • Sprigg N.
        • Wardlaw J.M.
        • ENOS Trial Investigators
        • et al.
        Relationship between poststroke cognition, baseline factors, and functional outcome: data from “efficacy of nitric oxide in stroke” trial.
        J Stroke Cerebrovasc Dis. 2014; 23: 1821-1829
        • Chaudhari T.S.
        • Verma R.
        • Garg R.K.
        • Singh M.K.
        • Malhotra H.S.
        • Sharma P.K.
        Clinico-radiological predictors of vascular cognitive impairment (VCI) in patients with stroke: a prospective observational study.
        J Neurol Sci. 2014; 340: 150-158
        • Bour A.M.
        • Rasquin S.M.
        • Baars L.
        • van Boxtel M.P.
        • Visser P.J.
        • Limburg M.
        • et al.
        The effect of the APOE-epsilon4 allele and ACE-I/D polymorphism on cognition during a two-year follow-up in first-ever stroke patients.
        Dement Geriatr Cogn Disord. 2010; 29: 534-542
        • Qian L.
        • Ding L.
        • Cheng L.
        • Zhu X.
        • Zhao H.
        • Jin J.
        • et al.
        Early biomarkers for post-stroke cognitive impairment.
        J Neurol. 2012; 259: 2111-2118
        • Gillespie D.C.
        • Bowen A.
        • Chung C.S.
        • Cockburn J.
        • Knapp P.
        • Pollock A.
        Rehabilitation for post-stroke cognitive impairment: an overview of recommendations arising from systematic reviews of current evidence.
        Clin Rehabil. 2015; 29: 120-128
        • Douiri A.
        • McKevitt C.
        • Emmett E.S.
        • Rudd A.G.
        • Wolfe C.D.
        Long-term effects of secondary prevention on cognitive function in stroke patients.
        Circulation. 2013; 128: 1341-1348
        • Alvarez-Sabín J.
        • Ortega G.
        • Jacas C.
        • Santamarina E.
        • Maisterra O.
        • Ribo M.
        • et al.
        Long-term treatment with citicoline may improve poststroke vascular cognitive impairment.
        Cerebrovasc Dis. 2013; 35: 146-154
        • Liu G.
        • Ntaios G.
        • Zheng H.
        • Wang Y.
        • Michel P.
        • Wang D.Z.
        • et al.
        External validation of the ASTRAL score to predict 3- and 12-month functional outcome in the China national stroke registry.
        Stroke. 2013; 44: 1443-1445
        • Papavasileiou V.
        • Milionis H.
        • Michel P.
        • Makaritsis K.
        • Vemmou A.
        • Koroboki E.
        • et al.
        ASTRAL score predicts 5-year dependence and mortality in acute ischemic stroke.
        Stroke. 2013; 44: 1616-1620
        • Muscari A.
        • Puddu G.M.
        • Santoro N.
        • Zoli M.A.
        simple scoring system for outcome prediction of ischemic stroke.
        Acta Neurol Scand. 2011; 124: 334-342
        • Strbian D.
        • Meretoja A.
        • Ahlhelm F.J.
        • Pitkaniemi J.
        • Lyrer P.
        • Kaste M.
        • et al.
        Predicting outcome of IV thrombolysis-treated ischemic stroke patients: the DRAGON score.
        Neurology. 2012; 78: 427-432
        • Giralt-Steinhauer E.
        • Rodriguez-Campello A.
        • Cuadrado-Godia E.
        • Ois A.
        • Jimenez-Conde J.
        • Soriano-Tarraga C.
        • et al.
        External validation of the DRAGON score in an elderly Spanish population: prediction of stroke prognosis after IV thrombolysis.
        Cerebrovasc Dis. 2013; 36: 110-114
        • Allen C.M.C.
        Predicting the outcome of acute stroke: a prognostic score.
        J Neurol Neurosurg Psychiatry. 1984; 47: 475-480
        • Gompertz P.
        • Pound P.
        • Ebrahim S.
        Predicting stroke outcome: guy's prognostic score in practice.
        J Neurol Neurosurg Psychiatry. 1994; 57: 932-935
        • Park T.H.
        • Saposnik G.
        • Bae H.J.
        • Lee S.J.
        • Lee K.B.
        • Lee J.
        • et al.
        The iScore predicts functional outcome in Korean patients with ischemic stroke.
        Stroke. 2013; 44: 1440-1442
        • Johnston K.C.
        • Connors A.F.
        • Wagner D.P.
        • Knaus W.A.
        • Wang X.Q.
        • Clarke Haley Jr., E.
        For the randomized trial of tirilazad mesylate in acute stroke (RANTTAS) investigators. A predictive risk model for outcomes of ischemic stroke.
        Stroke. 2000; 31: 448-455
        • Johnston K.C.
        • Connors A.F.
        • Wagner D.P.
        • Haley Jr., E.C.
        Predicting outcome in ischemic stroke. External validation of predictive risk models.
        Stroke. 2003; 34: 200-202
        • Reid J.M.
        • Gubitz G.J.
        • Dai D.
        • Kydd D.
        • Eskes G.
        • Reidy Y.
        • et al.
        Predicting functional outcome after stroke by modeling baseline clinical and CT variables.
        Age Ageing. 2010; 39: 360-366
        • Counsell C.
        • Dennis M.
        • M M.D.
        • Warlow C.
        Predicting outcome after acute and subacute stroke. Development and validation of new prognostic models.
        Stroke. 2002; 33: 1041-1047
        • Reid J.M.
        • Gubitz G.J.
        • Dai D.
        • Reidy Y.
        • Christian C.
        • Counsell C.
        • et al.
        External validation of a six simple variable model of stroke outcome and verification in hyper-acute stroke.
        J Neurol Neurosurg Psychiatry. 2007; 78: 1390-1391
        • Lewis S.C.
        • Sandercock P.A.
        • Dennis M.S.
        • SCOPE (Stroke Complications and Outcomes Prediction Engine) collaborations; IST
        Predicting outcome in hyper-acute stroke: validation of a prognostic model in the third international stroke trial (IST3).
        J Neurol Neurosurg Psychiatry. 2008; 79: 397-400
        • Kent D.M.
        • Selker H.P.
        • Ruthazer R.
        • Bluhmki E.
        • Hacke W.
        The stroke-thrombolytic predictive instrument: a predictive instrument for intravenous thrombolysis in acute ischemic stroke.
        Stroke. 2006; 37: 2957-2962
        • Uyttenboogaart M.
        • Stewart R.E.
        • Vroomen P.C.
        • Luijckx G.J.
        • De Keyser J.
        Utility of the stroke-thrombolytic predictive instrument.
        J Neurol Neurosurg Psychiatry. 2008; 79: 1079-1081
        • Weimar C.
        • Ziegler A.
        • Konig I.R.
        • Diener H.C.
        • on behalf of the German Stroke Study collaborators
        Predicting functional outcome and survival after acute ischemic stroke.
        J Neurol. 2002; 249: 888-895
        • German Stroke Study collaboration (gss)
        Predicting outcome after acute ischemic stroke: an external validation of prognostic models.
        Neurology. 2004; 62: 581-585
        • Weimar C.
        • Konig I.R.
        • Kraywinkel K.
        • Ziegler A.
        • Diener H.C.
        • On behalf of the German stroke study collaboration
        Age and National Institutes of Health Stroke Scale score within 6 hours after onset are accurate predictors of outcome after cerebral ischemia. Development and external validation of prognostic models.
        Stroke. 2004; 35: 158-162
        • Konig I.R.
        • Ziegler A.
        • Bluhmki E.
        • Hacke W.
        • PMW B.
        • Sacco R.L.
        • et al.
        On behalf of the Virtual International Stroke Trials Archive (VISTA) investigators. Predicting long-term outcome after acute ischemic stroke. A simple index works in patients from controlled clinical trials.
        Stroke. 2008; 39: 1821-1826
        • Saposnik G.
        • Guzik A.K.
        • Reeves M.
        • Ovbiagele B.
        • Johnston C.
        Stroke prognostication using age and NIH stroke scale. SPAN-100.
        Neurology. 2013; 80: 21-28
        • Pan Y.
        • Jing J.
        • Zhang R.
        • Zhao X.
        • Liu L.
        • Wang H.
        • et al.
        Poor performance of stroke prognostication using age and national institutes of health stroke scale-100 to predict 3- and 12-month outcomes of ischemic stroke in China national stroke registry.
        J Stroke Cerebrovasc Dis. 2014; 23: 2335-2340
        • Giralt-Steinhauer E.
        • Cuadrado-Godia E.
        • Ois A.
        • Jimenez-Conde J.
        • Rodriguez-Campello A.
        • Planellas L.
        • et al.
        CHA2DS2-VASc score and prognosis in ischemic strokes with atrial fibrillation.
        J Neurol. 2012; 259: 745-751
        • Potpara T.S.
        • Polovina M.M.
        • Djikic D.
        • Marinkovic J.M.
        • Kocev N.
        • GYH L.
        The association of CHA2DS2-VASc score and blood biomarkers with ischemic stroke outcomes: the Belgrade stroke study.
        PLoS One. 2014; 9e106439
        • Smith E.E.
        • Shobha N.
        • Dai D.
        • DWM O.
        • Reeves M.J.
        • Saver J.L.
        • et al.
        Risk score for in-hospital ischemic stroke mortality derived and validated within the get with the guidelines — stroke program.
        Circulation. 2010; 122: 1496-1504
        • Zhang N.
        • Liu G.
        • Zhang G.
        • Fang J.
        • Wang Y.
        • Zhao X.
        • et al.
        A risk score based on get with the guidelines — stroke program data works in patients with acute ischemic stroke in China.
        Stroke. 2012; 43: 3108-3109
        • Saposnik G.
        • Kapral M.K.
        • Liu Y.
        • Hall R.
        • O’Donnell M.
        • Raptis S.
        • on behalf of the investigators of the registry of the Canadian Stroke Network and the Stroke Outcomes Research Canada (SORCan) working group
        • et al.
        IScore: a risk score to predict death early after hospitalization for an acute ischemic stroke.
        Circulation. 2011; 123: 739-749
        • Lee J.
        • Morishima T.
        • Kunisawa S.
        • Sasaki N.
        • Otsubo T.
        • Ikai H.
        • et al.
        Derivation and validation of inhospital mortality prediction models in ischaemic stroke patients using administrative data.
        Cerebrovasc Dis. 2013; 35: 73-80
        • Williams G.R.
        • Jiang J.G.
        Development of an ischemic stroke survival score.
        Stroke. 2000; 31: 2414-2420
        • Myint P.K.
        • Clark A.B.
        • Kwok C.S.
        • Davis J.
        • Durairaj R.
        • Dixit A.K.
        • et al.
        The SOAR (stroke subtype, oxford community stroke project classification, age, prestroke modified Rankin) score strongly predicts early outcomes in acute stroke.
        Int J Stroke. 2014; 9: 278-283
        • Kwok C.S.
        • Potter J.F.
        • Dalton G.
        • George A.
        • Metcalf A.K.
        • Ngeh J.
        • on behalf of the Anglia Stroke Clinical Network Evaluation Study (ASCNES) group
        • et al.
        The SOAR stroke score predicts inpatient and 7-day mortality in acute stroke.
        Stroke. 2013; 44: 2010-2012
        • Solberg O.G.
        • Dahl M.
        • Mowinckel P.
        • Stavem K.
        Derivation and validation of a simple risk score for predicting 1-year mortality in stroke.
        J Neurol. 2007; 254: 1376-1383
        • Wang Y.
        • LLY L.
        • Heller R.F.
        • Fisher J.
        • Levi C.R.
        A prediction model of 1-year mortality for acute ischemic stroke patients.
        Arch Phys Med Rehabil. 2003; 84: 1006-1111
        • Bray B.D.
        • Campbell J.
        • Cloud G.C.
        • Hoffman A.
        • James M.
        • Tyrrell P.J.
        • on behalf of the Intercollegiate Stroke Working Party Group
        • et al.
        Derivation and external validation of a case mix model for the standardized reporting of 30-day stroke mortality rates.
        Stroke. 2014; 45: 3374-3380
        • Foerch C.
        • du Mesnil de Rochemont R.
        • Singer O.
        • Neumann-Haefelin T.
        • Buchkremer M.
        • Zanella F.E.
        • et al.
        S100B as a surrogate marker for successful clot lysis in hyperacute middle cerebral artery occlusion.
        J Neurol Neurosurg Psychiatry. 2003; 74: 322-325
        • Martí-Fàbregas J.
        • Borrell M.
        • Cocho D.
        • Belvís R.
        • Castellanos M.
        • Montaner J.
        • et al.
        Hemostatic markers of recanalization in patients with ischemic stroke treated with rt-PA.
        Neurology. 2005; 65: 366-370
        • Millan M.
        • Sobrino T.
        • Castellanos M.
        • Nombela F.
        • Arenillas J.F.
        • Riva E.
        • et al.
        Increased body iron stores are associated with poor outcome after thrombolytic treatment in acute stroke.
        Stroke. 2007; 38: 90-95
        • Choi K.H.
        • Park M.S.
        • Kim J.T.
        • Nam T.S.
        • Choi S.M.
        • Kim B.C.
        • et al.
        The serum ferritin level is an important predictor of hemorrhagic transformation in acute ischaemic stroke.
        Eur J Neurol. 2012; 19: 570-577
        • Hernandez-Guillamon M.
        • Garcia-Bonilla L.
        • Solé M.
        • Sosti V.
        • Parés M.
        • Campos M.
        • et al.
        Plasma VAP-1/SSAO activity predicts intracranial hemorrhages and adverse neurological outcome after tissue plasminogen activator treatment in stroke.
        Stroke. 2010; 41: 1528-1535
        • Llombart V.
        • Dominguez C.
        • Bustamante A.
        • Rodriguez-Sureda V.
        • Martín-Gallán P.
        • Vilches A.
        • et al.
        Fluorescent molecular peroxidation products: a prognostic biomarker of early neurologic deterioration after thrombolysis.
        Stroke. 2014; 45: 432-437
        • Merino-Zamorano C.
        • Hernández-Guillamon M.
        • Jullienne A.
        • Béhot A.L.
        • Bardou I.
        • Parés M.
        • et al.
        NURR1 involvement in recombinant tissue-type plasminogen activator treatment complications after ischemic Stroke.
        Stroke. 2015; 46: 477-484
        • Moldes O.
        • Sobrino T.
        • Millán M.
        • Castellanos M.
        • de la Ossa N P.
        • Leira R.
        • et al.
        High serum levels of endothelin-1 predict severe cerebral edema in patients with acute ischemic stroke treated with t-PA.
        Stroke. 2008; 39: 2006-2010
        • Rodríguez J.A.
        • Sobrino T.
        • Orbe J.
        • Purroy A.
        • Martínez-Vila E.
        • Castillo J.
        • et al.
        ProMetalloproteinase-10 is associated with brain damage and clinical outcome in acute ischemic stroke.
        J Thromb Haemost. 2013; 11: 1464-1473
        • Hug A.
        • Mürle B.
        • Dalpke A.
        • Zorn M.
        • Liesz A.
        • Veltkamp R.
        Usefulness of serum procalcitonin levels for the early diagnosis of stroke-associated respiratory tract infections.
        Neurocrit Care. 2011; 14: 416-422
        • Zhang X.
        • Wang F.
        • Zhang Y.
        • Ge Z.
        Risk factors for developing pneumonia in patients with diabetes mellitus following acute ischaemic stroke.
        J Int Med Res. 2012; 40: 1860-1865
        • Reding M.
        • Orto L.
        • Willensky P.
        • Fortuna I.
        • Day N.
        • Steiner S.F.
        • et al.
        The dexamethasone suppression test. An indicator of depression in stroke but not a predictor of rehabilitation outcome.
        Arch Neurol. 1985; 42: 209-212
        • Yang L.
        • Zhang Z.
        • Sun D.
        • Xu Z.
        • Yuan Y.
        • Zhang X.
        • et al.
        Low serum BDNF may indicate the development of PSD in patients with acute ischemic stroke.
        Int J Geriatr Psychiatry. 2011; 26: 495-502
        • Yang L.
        • Zhang Z.
        • Sun D.
        • Xu Z.
        • Zhang X.
        • Li L.
        The serum interleukin-18 is a potential marker for development of post-stroke depression.
        Neurol Res. 2010; 32: 340-346
        • Pascoe M.C.
        • Crewther S.G.
        • Carey L.M.
        • Noonan K.
        • Crewther D.P.
        • Linden T.
        Homocysteine as a potential biochemical marker for depression in elderly stroke survivors.
        Food Nutr Res. 2012; : 56
        • Li Y.
        • Wang X.
        • Yang Z.
        Neuron-specific enolase in patients with acute ischemic stroke and related dementia.
        Chin Med J (Engl). 1995; 108: 221-223
        • Rothenburg L.S.
        • Herrmann N.
        • Swardfager W.
        • Black S.E.
        • Tennen G.
        • Kiss A.
        • et al.
        The relationship between inflammatory markers and post stroke cognitive impairment.
        J Geriatr Psychiatry Neurol. 2010; 23: 199-205
        • Gold A.B.
        • Herrmann N.
        • Swardfager W.
        • Black S.E.
        • Aviv R.I.
        • Tennen G.
        • et al.
        The relationship between indoleamine 2, 3-dioxygenase activity and post-stroke cognitive impairment.
        J Neuroinflammation. 2011; 8: 17
        • Kliper E.
        • Bashat D.B.
        • Bornstein N.M.
        • Shenhar-Tsarfaty S.
        • Hallevi H.
        • Auriel E.
        • et al.
        Cognitive decline after stroke: relation to inflammatory biomarkers and hippocampal volume.
        Stroke. 2013; 44: 1433-1435
        • Cucchiara B.
        • Tanne D.
        • Levine S.R.
        • Demchuk A.M.
        • Kasner S.
        A risk score to predict intracranial hemorrhage after recombinant tissue plasminogen activator for acute ischemic stroke.
        J Stroke Cerebrovasc Dis. 2008; 17: 331-333
        • Mazya M.
        • Egido J.A.
        • Ford G.A.
        • Lees K.R.
        • Mikulik R.
        • Toni D.
        • SITS Investigators
        • et al.
        Predicting the risk of symptomatic intracerebral hemorrhage in ischemic stroke treated with intravenous alteplase: safe Implementation of Treatments in Stroke (SITS) symptomatic intracerebral hemorrhage risk score.
        Stroke. 2012; 43: 1524-1531
        • Kwon H.M.
        • Jeong S.W.
        • Lee S.H.
        • Yoon B.W.
        The pneumonia score: a simple grading scale for prediction of pneumonia after acute stroke.
        Am J Infect Control. 2006; 34: 64-68
        • Chumbler N.R.
        • Williams L.S.
        • Wells C.K.
        • Lo A.C.
        • Nadeau S.
        • Peixoto A.J.
        • et al.
        Derivation and validation of a clinical system for predicting pneumonia in acute stroke.
        Neuroepidemiology. 2010; 34: 193-199